A Phase 1,Randomized, Double--Blind, Placebo-Controlled Study Assessing the Safety and Tolerability, the Pharmacodynamics and Pharmacokinetics of Single-Ascending and Repeated Doses of Inhaled TPI 1100 in Healthy Subjects.
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 30 Nov 2012
At a glance
- Drugs TPI 1100 (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions
- 15 Mar 2011 Status changed from suspended to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 18 Jun 2009 New trial record